Brown-Forman Rejects $15 Billion Takeover Bid from Sazerac
The rejection follows Brown-Forman ending merger talks with the French spirits maker Pernod Ricard late last month.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
The rejection follows Brown-Forman ending merger talks with the French spirits maker Pernod Ricard late last month.
C3 AI met revenue goals, reduced losses, saw the CEO return, and achieved cost savings, but weak bookings hit shares.
Reuters says Tesla robotaxis in Texas are still rough: long waits, few cars, bad drop-offs, and mostly still in beta.
Quantum Computing stock jumps after strong sales, smart deals, and new AI tech that uses light for faster, low-power performance.
D-Wave revenue missed but loss smaller; bookings surged to $33.4M from big deals.
Under Armour fell after weak outlook, higher costs, and lower sales expected, though profits and margins may improve slightly.